EAM Investors, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$2,466,658
-32.1%
155,429
-19.3%
0.48%
-29.3%
Q2 2023$3,632,834
-8.0%
192,519
-48.7%
0.67%
+2.4%
Q1 2018$3,947,000
-12.7%
375,205
-36.5%
0.66%
+9.3%
Q3 2017$4,519,000
+9.0%
590,708
+1.3%
0.60%
-12.3%
Q2 2017$4,144,000582,8650.68%
Other shareholders
IMMUNOGEN INC shareholders Q1 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders